Announcement on Resuming Production in Anhui North Carolina, a Subsidiary Company
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group Announcement No.: Pro 2018-021
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Announcement of Zhejiang Jianfeng Group Co., Ltd.
on Resuming Production of Subsidiary Anhui Beika
|
Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "the Company" or "the Company") received its subsidiary Anhui Xinbeika Chemical Co., Ltd. (hereinafter referred to as "Anhui") on July 17, 2018 north Carolina ") notice, after rectification, Anhui Beika submitted the" Report on Request for Resuming Production "to the Dongzhi County Environmental Protection Bureau. According to the provisions of Article 17 of the" Measures for the Implementation of Restrictions on Production and Suspension of Production by the Environmental Protection Department "(Order No. 30 of the Ministry of Environmental Protection of the People's Republic of China) (hereinafter referred to as" Measures for Suspension of Production "), it was filed by the Dongzhi County Environmental Protection Bureau on July 16:
1. Suspension of ProductionOn July 3, 2018
, the Dongzhi County Environmental Protection Bureau issued a" Decision on Ordering Suspension of Production and Remediation "(Donghuan Ziping [2018]04) to Anhui Beika, ordering Anhui Beika to implement suspension of production and remediation (see" 2018-020 "for details, see" Announcement on Subsidiaries Receiving Decision of Environmental Protection Department Ordering Suspension of Production and Remediation "). Rectification of 2.
After receiving the decision, Anhui Beika stopped production in strict accordance with the requirements of the Decision on Ordering Suspension of Production and Rectification. The company instructed Jianfeng Pharmaceutical to immediately set up an emergency working group for environmental protection incidents to investigate and supervise the rectification of the incident. Anhui Beika has set up an emergency working group for shutdown and rectification, formulated and implemented a rectification plan, and adjusted environmental protection management agencies and personnel; further improve the company's environmental protection capacity.
3. Resuming Production
According to Article 17 of the Measures for Suspension of Production and Remediation: "If the polluter completes the rectification task, he shall report the completion of the rectification task and the public disclosure of the rectification information to the competent environmental protection department that made the decision to restrict production and suspend production for rectification within 15 working days, and submit monitoring reports and materials such as electricity consumption, water consumption, output of major products and comparison before rectification during the rectification period. The decision to restrict production and stop production for rectification shall be lifted from the date on which the polluter reports to the competent environmental protection department for the record."
Anhui Beika submitted "Report on Request for Resuming Production" and other relevant materials to Dongzhi County Environmental Protection Bureau on July 16, 2018
, and obtained the record of Dongzhi County Environmental Protection Bureau.The decision on Anhui Beika "Stop Production and Remediation" listed in the "Decision on Ordering to Stop Production and Remediation" (Donghuan Responsibility Stop [2018] No. 04) of Dongzhi County Environmental Protection Bureau has been lifted . Anhui Beika is starting to carry out material preparation, equipment and facilities inspection, personnel training and other work, and will start feeding and resume production within a week.
Impact of 4. Shutdown
Anhui Beika is a newly acquired holding subsidiary of the Company.
Its total assets and operating income account for a small proportion of the Company's total assets and income.The shutdown time is short and has not had a significant impact on the Company's operation.
5. Reference Document
Anhui Beika Resuming Production Relevant Document Filing Material
is hereby announced.
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
2018
July 18, 96
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page